Wright, David J. http://orcid.org/0000-0003-1799-8447
Simmons, Katie J.
Johnson, Rachel M.
Beech, David J. http://orcid.org/0000-0002-7683-9422
Muench, Stephen P. http://orcid.org/0000-0001-6869-4414
Bon, Robin S. http://orcid.org/0000-0003-1733-3680
Funding for this research was provided by:
RCUK | Biotechnology and Biological Sciences Research Council (BB/P020208/1, BB/P020208/1, BB/P020208/1)
Wellcome Trust (102174/B/13/Z)
Article History
Received: 23 April 2020
Accepted: 23 October 2020
First Online: 23 November 2020
Competing interests
: The authors declare the following competing interests: David J. Beech is an inventor on the following patent applications: (1) PCT/GB2018/050369. TRPC ion channel inhibitors for use in therapy. Filing date: 9th February 2018. Inventors: David J. Beech, Richard J. Foster, Sin Ying Cheung and Baptiste M Rode; (2) 62/529,063. Englerin derivatives for the treatment of cancer. Filing date: 6th July 2017. Inventors: John A. Beutler, Antonio Echavarren, William Chain, David Beech, Zhenhua Wu, Jean-Simon Suppo, Fernando Bravo and Hussein Rubaiy.